EUVIMEDEUVIMED entdecken
Multizentrische Studie

Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus

Wenhang Yang, Xue Li, Jiawei Chen, Ge Zhang, Jin Li, Jingjia Zhang, Tong Wang, Wei Kang, Haotian Gao, Zhijie Zhang, Yong Liu, Yuling Xiao und 12 weitere

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae331 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Wenhang Yang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medi…. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Anti-Bacterial Agents, Enterococcus, Staphylococcus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National High Level Hospital Clinical Research Funding, Special Foundation for National Science and Technology Basic Research Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To investigate susceptibility to contezolid, a novel oxazolidinone, multicentre surveillance was conducted involving 2449 strains of Staphylococcus and Enterococcus collected from 65 hospitals across China.

Methods

The MICs of contezolid, linezolid and other clinically significant antibiotics were determined by the broth microdilution method. Consistency with the broth microdilution method for contezolid was assessed using agar dilution method, as well as disc diffusion and ETEST for linezolid, respectively. WGS was conducted on all 20 linezolid-resistant and 30 randomly non-resistant strains to analyse linezolid resistance genes (optrA, poxtA, cfr) and 23S rRNA mutation sites.

Results

All strains exhibited WT susceptibility to contezolid, while resistance proportions to daptomycin, vancomycin, teicoplanin, tigecycline and eravacycline ranged from 0% to 5.2% in Staphylococcus, and from 0% to 7.8% in Enterococcus. Linezolid resistance was higher in Enterococcus faecalis (4.4%) compared with Enterococcus faecium (0.2%). Contezolid showed a lower MIC50 (0.5 mg/L) than linezolid (2 mg/L) for methicillin-resistant Staphylococcus. Against Enterococcus, contezolid demonstrated a cumulative MIC percentage of 70% for VRE and 39.1% for E. faecalis (at MIC = 1 mg/L), whereas linezolid showed 0% and 1.1%, respectively. Among the 20 linezolid-resistant Enterococcus strains, all carried the optrA gene without 23S rRNA mutations. For contezolid, MICs were 4 mg/L for 19 strains and 2 mg/L for 1 strain. The ETEST, agar dilution and disc diffusion methods showed essential and categorical agreements of >90% for linezolid, with no major errors or very major errors.

Conclusions

Contezolid demonstrated significant in vitro antibacterial activity against methicillin-resistant Staphylococcus, VRE and linezolid-resistant E. faecalis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microbial Sensitivity TestsAnti-Bacterial AgentsEnterococcusStaphylococcusLinezolidOxazolidinonesHumansChinaGram-Positive Bacterial InfectionsDrug Resistance, BacterialRNA, Ribosomal, 23SStaphylococcal InfectionsWhole Genome SequencingEnterococcus faecalisMutationPyridones

Substanzen

Anti-Bacterial AgentsLinezolidOxazolidinonescontezolidRNA, Ribosomal, 23SPyridones

Autor:innen und Institutionen

  • Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wan…
  • Department of Laboratory Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Hebei Provincial Center for Clinical Laboratories, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
  • Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Center of Medical Laboratory, General Hospital of Ningxia Medical University, Yinchuan, China.

Förderung

  • National High Level Hospital Clinical Research Funding
  • Special Foundation for National Science and Technology Basic Research Program of China

Zitieren

APA

Yang, W., Li, X., Chen, J., Zhang, G., Li, J., Zhang, J., Wang, T., Kang, W., Gao, H., Zhang, Z., Liu, Y., Xiao, Y., Xie, Y., Zhao, J., Mao, L., Sun, Z., Li, G., Jia, W., Song, G., …, & Liu, Y. (2024). Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae331

Vancouver

Yang W, Li X, Chen J, Zhang G, Li J, Zhang J, et al. Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae331

BibTeX
@article{Yang2024,
  author = {Yang, Wenhang and Li, Xue and Chen, Jiawei and Zhang, Ge and Li, Jin and Zhang, Jingjia and Wang, Tong and Kang, Wei and Gao, Haotian and Zhang, Zhijie and Liu, Yong and Xiao, Yuling and Xie, Yi and Zhao, Jianhong and Mao, Liyan and Sun, Ziyong and Li, Gang and Jia, Wei and Song, Guibo and Shan, Bin and Yu, Yanhua and Sun, Guizhen and Xu, Yingchun and Liu, Yali},
  title = {Multicentre evaluation of in vitro activity of contezolid against drug-resistant Staphylococcus and Enterococcus},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae331}
}
Kostenlos starten →